Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis.
Moulin D, Millard M, Taïeb M, Michaudel C, Aucouturier A, Lefèvre A, Bermúdez-Humarán LG, Langella P, Sereme Y, Wanherdrick K, Gautam P, Mariette X, Dieudé P, Gottenberg JE, Jouzeau JY, Skurnik D, Emond P, Mulleman D, Sellam J, Sokol H. Moulin D, et al. Among authors: mulleman d. Ann Rheum Dis. 2024 Feb 15;83(3):312-323. doi: 10.1136/ard-2023-224014. Ann Rheum Dis. 2024. PMID: 38049981 Free PMC article.
Towards an individualised target concentration of adalimumab in rheumatoid arthritis.
Ducourau E, Ternant D, Lequerré T, Fuzibet P, Le Loët X, Watier H, Goupille P, Paintaud G, Vittecoq O, Mulleman D. Ducourau E, et al. Among authors: mulleman d. Ann Rheum Dis. 2014 Jul;73(7):1428-9. doi: 10.1136/annrheumdis-2013-204971. Epub 2014 Feb 18. Ann Rheum Dis. 2014. PMID: 24550169 No abstract available.
International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus.
Kleinmann JF, Tubach F, Le Guern V, Mathian A, Richez C, Saadoun D, Sacre K, Sellam J, Seror R, Amoura Z, Andres E, Audia S, Bader-Meunier B, Blaison G, Bonnotte B, Cacoub P, Caillard S, Chiche L, Chosidow O, Costedoat-Chalumeau N, Daien C, Daugas E, Derdèche N, Doria A, Fain O, Fakhouri F, Farge D, Gabay C, Guillo S, Hachulla E, Hajjaj-Hassouni N, Hamidou M, Houssiau FA, Jourde-Chiche N, Koné-Paut I, Ladjouz-Rezig A, Lambotte O, Lipsker D, Mariette X, Martin-Silva N, Martin T, Maurier F, Meckenstock R, Mékinian A, Meyer O, Mohamed S, Morel J, Moulin B, Mulleman D, Papo T, Poindron V, Puéchal X, Punzi L, Quartier P, Sailler L, Smail A, Soubrier M, Sparsa A, Tazi-Mezalek Z, Zakraoui L, Zuily S, Sibilia J, Gottenberg JE. Kleinmann JF, et al. Among authors: mulleman d. Autoimmun Rev. 2017 Jun;16(6):650-657. doi: 10.1016/j.autrev.2017.04.011. Epub 2017 Apr 18. Autoimmun Rev. 2017. PMID: 28434948
Management and outcome of native joint septic arthritis: a nationwide survey in French rheumatology departments, 2016-2017.
Richebé P, Coiffier G, Guggenbuhl P, Mulleman D, Couderc M, Dernis E, Deprez V, Salliot C, Urien S, Brault R, Ruyssen-Witrand A, Hoppe E, Chatelus E, Roux CH, Ottaviani S, Baufrere M, Michaut A, Pauvele L, Darrieutort-Laffite C, Wendling D, Coquerelle P, Bart G, Gervais E, Goeb V, Ardizzone M, Pertuiset E, Derolez S, Ziza JM, Flipo RM, Godot S, Seror R. Richebé P, et al. Among authors: mulleman d. Ann Rheum Dis. 2022 Jul 12:annrheumdis-2022-222143. doi: 10.1136/ard-2022-222143. Online ahead of print. Ann Rheum Dis. 2022. PMID: 35820674
Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trial.
Chevalier X, Ravaud P, Maheu E, Baron G, Rialland A, Vergnaud P, Roux C, Maugars Y, Mulleman D, Lukas C, Wendling D, Lafforgue P, Loeuille D, Foltz V, Richette P; French section of osteoarthritis. Chevalier X, et al. Among authors: mulleman d. Ann Rheum Dis. 2015 Sep;74(9):1697-705. doi: 10.1136/annrheumdis-2014-205348. Epub 2014 May 9. Ann Rheum Dis. 2015. PMID: 24817417 Clinical Trial.
Recherche translationnelle dans les pathologies immuno-inflammatoires : quels défis, quels progrès attendre, pour quelles innovations thérapeutiques ?
Joubert JM, Gottenberg JE, Paintaud G; et les membres de la table ronde N° 2 de Giens XXIX; Augendre-Ferrante B, Cans C, Cellier D, Chevalier MP, Diaz I, Filipecki J, Kahn JE, Le Men J, Mulleman D, Urbain R, Vasmant D. Joubert JM, et al. Among authors: mulleman d. Therapie. 2014 Jul-Aug;69(4):291-6. doi: 10.2515/therapie/2014049. Therapie. 2014. PMID: 27393224 French. No abstract available.
Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial.
Soubrier M, Puéchal X, Sibilia J, Mariette X, Meyer O, Combe B, Flipo RM, Mulleman D, Berenbaum F, Zarnitsky C, Schaeverbeke T, Fardellone P, Dougados M. Soubrier M, et al. Among authors: mulleman d. Rheumatology (Oxford). 2009 Nov;48(11):1429-34. doi: 10.1093/rheumatology/kep261. Epub 2009 Sep 9. Rheumatology (Oxford). 2009. PMID: 19741011 Clinical Trial.
Translational research in immune and inflammatory diseases; what are the challenges, expected advances, and innovative therapies?
Joubert JM, Gottenberg JE, Paintaud G; participants of round table N2 of Giens XXIX: Augendre-Ferrante Béatrice 4 Cans Christophe 5 Cellier Dominique 6; Augendre-Ferrante B, Cans C, Cellier D, Chevalier MP, Diaz I, Filipecki J, Kahn JE, Le Men J, Mulleman D, Urbain R, Vasmant D. Joubert JM, et al. Among authors: mulleman d. Therapie. 2014 Jul-Aug;69(4):291-302. doi: 10.2515/therapie/2014050. Epub 2014 Aug 8. Therapie. 2014. PMID: 25099671 English, French.
107 results